跳至主要内容
临床试验/ISRCTN11236443
ISRCTN11236443进行中(未招募)3 期

Sodium oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study

Amsterdam UMC Location VUmc0 个研究点目标入组 42 人开始时间: 2024年6月3日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients (age 18 years and over)
  • 2. Admition to an acute psychiatric ward for the treatment of catatonia, not responedingto usual care (i.e., increasing doses of lorazepam to a maximum of 24 mg during 4 days).
  • 3. DSM-5 classification of either unipolar depressive disorder, bipolar disorder or a psychotic disorder
  • 4. Catatonia is present for a maximum of eight weeks.

排除标准

  • 1. Not able to take drugs orally, i.e., subjects who actively resist treatment, and are thus not able/or want to take oral sodium oxybate
  • 2. Somatic disorder underlying catatonia
  • 3. Use of anti-psychotic drugs if patients prior to the development of catatonia either had an increase or change in anti-psychotic medication. Patients that have been treated with a stable dose of antipsychotics for a longer period of time should be allowed to be treated further with anti-psychotic medication if the patient’s treating psychiatrist deems this necessary and catatonia is mild, i.e. BFRCS <9
  • 4. Known heart failure or renal impairment due to significant amounts of sodium in the sodium oxybate
  • 5. Known sleep apnoea.
  • 6.1. Use of GABAergic drugs including gabapentin, pregabalin and clonidine
  • 6.2. Use of GHB dehydrogenase inhibitors, including valproate, phenytoin and ethosuximide
  • 6.3. Use of opioids, except tramadol
  • 7. Presence of alcohol use disorder
  • 8. Presence of malignant catatonia (as is indicated by autonomic dysregulation, item 23 of the Bush Francis Catatonia rating scale, scoring 3 combined with moderately severe to severe muscle rigidity, item 11 of the Bush Francis Catatonia rating scale, scoring 2 or higher) or development of malignant catatonia during the study
  • Patients with malignant catatonia need to receive treatment with ECT as soon as possible since mortality in those with untreated catatonia ranges between 10 and 40%

研究者

发起方
Amsterdam UMC Location VUmc

相似试验